Skip to main content
SpringerLink
Log in
Book cover

Komplikationen und Gefahren in der Anästhesie pp 343–351Cite as

Perioperative dentale Komplikationen

  • Chapter

  • 95 Accesses

Zusammenfassung

Perioperative Gerinnungsstörungen

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ammar T, Fisher CF (1997) The effects of heparinase 1 and protamine on platelet reactivity. Anesthesiology 86: 1382–6

    Article  PubMed  CAS  Google Scholar 

  2. ASA(1996) Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 84: 732–47

    Google Scholar 

  3. Barthels M, Poliwoda H (1993) Gerinnungsanalysen: Interpretation, Schnellorientierung, Therapiekontrollen, 4. Thieme, Stuttgart New York

    Google Scholar 

  4. Bauer KA, Rosenberg RD (1987) The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood 70: 343–50

    PubMed  CAS  Google Scholar 

  5. Beilin Y, Zahn J, Comerford M (1997) Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000 mm-3. Anesth Analg 85: 385–8

    PubMed  CAS  Google Scholar 

  6. Benoni G, Fredin H (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 78: 434–40

    PubMed  CAS  Google Scholar 

  7. Bonnar J, Sheppard BL (1996) Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 313: 579–82

    Article  PubMed  CAS  Google Scholar 

  8. Boylan JF, Klinck JR, Sandier AN, et al. (1996) Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 85: 1043–8

    Article  PubMed  CAS  Google Scholar 

  9. Capdevila X, Calvet Y, Biboulet P, et al. (1998) Aprotinin decreases blood loss and homologous transfusions in patients undergoing major orthopedic surgery. Anesthesiology 88: 50–7

    Article  PubMed  CAS  Google Scholar 

  10. Ciavarella D, Reed RL, Counts RB, et al. (1987) Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 67: 365–8

    Article  PubMed  CAS  Google Scholar 

  11. Contreras M, Ala FA, Greaves M, et al. (1992) Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med 2: 57–63

    Article  PubMed  CAS  Google Scholar 

  12. Cox SR, VanderLugt JT, Gumbleton TJ, Smith RB (1987) Relationships between thromboxane production, platelet aggregability, and serum concentrations of ibuprofen or flurbiprofen. Clin Pharmacol Ther 41: 510–21

    Article  PubMed  CAS  Google Scholar 

  13. Creasey AA, Chang AC, Feigen L, et al. (1993) Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 91: 2850–6

    Article  PubMed  CAS  Google Scholar 

  14. Daily PO, Lamphere JA, Dembitsky WP, et al. (1994) Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study. J Thorac Cardiovasc Surg 108: 99–106

    PubMed  CAS  Google Scholar 

  15. Dehmer GJ, Lange RA, Tate DA, et al. (1996) Randomized trial of recombinant platelet factor 4 vs. protamine for the reversal of heparin anticoagulation in humans. Circulation 94: II347-52

    Google Scholar 

  16. Despotis GJ, Filos KS, Zoys TN, et al. (1996) Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 82: 13–21

    PubMed  CAS  Google Scholar 

  17. Dietrich W, Spannagl M, Jochum M, et al. (1990) Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology 73: 1119–26

    Article  PubMed  CAS  Google Scholar 

  18. Dietrich W, Spath P, Ebell A, Richter JA (1997) Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 113: 194–201

    Article  PubMed  CAS  Google Scholar 

  19. Dilthey G, Dietrich W, Spannagl M, Richter JA (1993) Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. J Cardiothorac Anesth 7: 425–30

    Article  CAS  Google Scholar 

  20. Feinstein DI (1982) Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood 60: 284–7

    PubMed  CAS  Google Scholar 

  21. Fourrier F, Chopin C, Goudemand J, et al. (1992) Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 101: 816–23

    Article  PubMed  CAS  Google Scholar 

  22. Gando S, Kameue T, Nanzaki S, Nakanishi Y (1996) Disseminated intravascular coagulation is a frequent complication of systemic inFlammatory response syndrome. Thromb Haemost 75: 224–8

    PubMed  CAS  Google Scholar 

  23. Gando S, Nakanishi Y, Tedo I (1995) Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med 23: 1835–42

    Article  PubMed  CAS  Google Scholar 

  24. Havel M, Grabenwoger F, Schneider J, et al. (1994) Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. J Thorac Cardiovasc Surg 107: 807–10

    PubMed  CAS  Google Scholar 

  25. Henry DA, O’Connell DL (1989) Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. BMJ 298: 1142–6

    Article  PubMed  CAS  Google Scholar 

  26. Hiippala ST, Strid LJ, Wennerstrand MI, et al. (1997) Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 84: 839–44

    PubMed  CAS  Google Scholar 

  27. Hindman BJ, Koka BV (1986) Usefulness of the post-aspirin bleeding time. Anesthesiology 64: 368–70

    Article  PubMed  CAS  Google Scholar 

  28. Horlocker TT, Wedel DJ (1998) Neuraxial block and low-molecular-weight heparin: balancing perioperative analgesia and thromboprophylaxis. Reg Anesth Pain Med 23: 164–77

    PubMed  CAS  Google Scholar 

  29. Horrow JC, Van Riper DF, Strong MD, et al. (1995) The dose-response relationship of tranexamic acid. Anesthesiology 82: 383–92

    Article  PubMed  CAS  Google Scholar 

  30. Kallis P, Tooze JA, Talbot S et al. (1994) Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss — a prospective, randomised, placebo controlled, doubleblind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg 8: 404–9

    Article  PubMed  CAS  Google Scholar 

  31. Kapiotis S, Quehenberger P, Eichler HG, et al. (1994) Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Crit Care Med 22: 606–12

    Article  PubMed  CAS  Google Scholar 

  32. Katsaros D, Petricevic M, Snow NJ, et al. (1996) Tranexamic acid reduces postbypass blood use: a double-blinded, prospective, randomized study of 210 patients. Ann Thorac Surg 61:1131–5

    Article  PubMed  CAS  Google Scholar 

  33. Kobrinsky NL, Israels ED, Gerrard JM, et al. (1984) Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet 1: 1145–8

    Article  PubMed  CAS  Google Scholar 

  34. Kohler M, Hellstern P, Miyashita C, et al. (1986) Comparative study of intranasal, subcutaneous and intravenous administration of desamino-Darginine vasopressin (DDAVP). Thromb Haemost 55: 108–11

    PubMed  CAS  Google Scholar 

  35. Lass M, Welz A, Kochs M, et al. (1995) Aprotinin in elective primary bypass surgery. Graft patency and clinical efficacy. Eur J Cardiothorac Surg 9: 206–10

    Article  PubMed  CAS  Google Scholar 

  36. Lemmer JH, Jr., Stanford W, Bonney SL, et al. (1994) Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg 107: 543–51

    Google Scholar 

  37. Lethagen S, Harris AS, Sjorin E, Nilsson IM (1987) Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility. Thromb Haemost 58: 1033–6

    PubMed  CAS  Google Scholar 

  38. Levi M, Ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341: 586–92

    Article  PubMed  CAS  Google Scholar 

  39. Levi M, van der Poll T, ten Cate H, van Deventer SJ (1997) The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest 27: 3–9

    Article  PubMed  CAS  Google Scholar 

  40. Levy JH, Cormack JG, Morales A (1995) Heparin neutralization by recombinant platelet factor 4 and protamine. Anesth Analg 81: 35–7

    PubMed  CAS  Google Scholar 

  41. Lind SE (1991) The bleeding time does not predict surgical bleeding. Blood 77: 2547–52

    PubMed  CAS  Google Scholar 

  42. Livio M, Mannucci PM, Vigano G, et al. (1986) Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 315: 731–5

    Article  PubMed  CAS  Google Scholar 

  43. Mallett SV, Cox D, Burroughs AK, Rolles K (1990) Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation. Lancet 336: 886–7

    Article  PubMed  CAS  Google Scholar 

  44. Mannucci PM (1998) Hemostatic drugs. N Engl J Med 339: 245–53

    Article  PubMed  CAS  Google Scholar 

  45. Mannucci PM, Remuzzi G, Pusineri F, et al. (1983) Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308: 8–12

    Article  PubMed  CAS  Google Scholar 

  46. Mannucci PM, Vicente V, Vianello L, et al. (1986) Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 67: 1148–53

    PubMed  CAS  Google Scholar 

  47. Martin E, Fleischer F, (Hrsg) (1993) Perioperative Gerinnungsstörungen. Diagnostik und Therapie, 1. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  48. Michelsen LG, Kikura M, Levy JH, et al. (1996) Heparinase I (neutralase) reversal of systemic anticoagulation. Anesthesiology 85: 339–46

    Article  PubMed  CAS  Google Scholar 

  49. Miller RA, May MW, Hendry WF, et al. (1980) The prevention of secondary haemorrhage after prostatectomy: the value of antifibrinolytic therapy. Br J Urol 52: 26–8

    Article  PubMed  CAS  Google Scholar 

  50. Moia M, Mannucci PM, Vizzotto L, et al. (1987) Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet 2: 1227–9

    Article  PubMed  CAS  Google Scholar 

  51. Murphy MF, Brozovic B, Murphy W, et al. (1992) Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med 2: 311–8

    Article  PubMed  CAS  Google Scholar 

  52. Murray DJ, Olson J, Strauss R, Tinker JH (1988) Coagulation changes during packed red cell replacement of major blood loss. Anesthesiology 69: 839–45

    Article  PubMed  CAS  Google Scholar 

  53. O’Kelly SW, Lawes EG, Luntley JB (1992) Bleeding time: is it a useful clinical tool? Br J Anaesth 68: 313–5

    Article  CAS  Google Scholar 

  54. Patrassi GM, Viero M, Sartori MT, et al. (1994) Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation. Transfusion 34: 507–11

    Article  PubMed  CAS  Google Scholar 

  55. Prendergast TW, Furukawa S, Beyer AJ, 3rd, et al. (1996) Defining the role of aprotinin in heart transplantation. Ann Thorac Surg 62: 670–4

    Article  PubMed  CAS  Google Scholar 

  56. Rasche H (1994) Perioperative Gerinnungsstörungen. In: D.A.f.A. Fortbildung (Hrsg) Refresher Course Aktuelles Wissen für Anästhesisten, Nr. 20, Juni 1994, Nürnberg, Springer, Berlin Heidelberg New York Tokyo, S 59–71

    Chapter  Google Scholar 

  57. Regoeczi E, Brain MC (1969) Organ distribution of fibrin in disseminated intravascular coagulation. Br J Haematol 17: 73–81

    Article  PubMed  CAS  Google Scholar 

  58. Reich DL, Patel GC, Vela-Cantos F, et al. (1994) Aspirin does not increase homologous blood requirements in elective coronary bypass surgery. Anesth Analg 79: 4–8

    Article  PubMed  CAS  Google Scholar 

  59. Sakuragawa N, Hasegawa H, Maki M, et al. (1993) Clinical evaluation of low-molecularweight heparin (FR-860) on disseminated intravascular coagulation (DlC)-a multicenter cooperative double-blind trial in comparison with heparin. Thromb Res 72: 475–500

    Article  PubMed  CAS  Google Scholar 

  60. Sauer W, Schwagmeier R, Nolte H (1992) Dauermedikation mit Acetylsalicylsäure — ein Problem für die Regionalanästhesie? Anästhesist 41: 489–93

    CAS  Google Scholar 

  61. Schafer AI (1999) Effects of nonsteroidal antiinFlammatory therapy on platelets. Am J Med 106: 25S–36S

    Article  PubMed  CAS  Google Scholar 

  62. Sheridan DP, Card RT, Pinilla JC, et al. (1994) Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction. Can J Surg 37: 33–6

    PubMed  CAS  Google Scholar 

  63. Stefanini M, English HA, Taylor AE (1990) Safe and effective, prolonged administration of epsilon aminocaproic acid in bleeding from the urinary tract. J Urol 143: 559–61

    PubMed  CAS  Google Scholar 

  64. Strauss RG, Stansfield C, Henriksen RA, Villhauer PJ (1988) Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 28: 257–60

    Article  PubMed  CAS  Google Scholar 

  65. Tabuchi N, Huet RC, Sturk A, et al. (1995) Hemostatic function of aspirin-treated platelets vulnerable to cardiopulmonary bypass. Altered shear-induced pathway. J Thorac Cardiovasc Surg 110: 813–8

    Article  PubMed  CAS  Google Scholar 

  66. Troianos CA, Sypula RW, Lucas DM, et al. (1999) The effect of prophylactic e-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting. Anesthesiology 91: 430–5

    Article  PubMed  CAS  Google Scholar 

  67. Tuman KJ, McCarthy RJ, O’Connor CJ, et al. (1996) Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery. Anesth Analg 83: 1178–84

    PubMed  CAS  Google Scholar 

  68. Verstraete M (1985) Clinical application of inhibitors of fibrinolysis. Drugs 29: 236–61

    Article  PubMed  CAS  Google Scholar 

  69. Vigano GL, Mannucci PM, Lattuada A, et al. (1989) Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia. Am J Hematol 31:32–5

    Article  PubMed  CAS  Google Scholar 

  70. Vuylsteke A, Oduro A, Cardan E, Latimer RD (1997) Effect of aspirin in coronary artery bypass grafting. J Cardiothorac Anesth 11: 831–4

    Article  CAS  Google Scholar 

  71. Wada H, Wakita Y, Nakase T, et al. (1996) Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Am J Hematol 51: 255–60

    Article  PubMed  CAS  Google Scholar 

  72. Wahba A, Black G, Koksch M, et al. (1996) Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass. Thromb Haemost 75: 844–8

    PubMed  CAS  Google Scholar 

  73. Winearls CG, Oliver DO, Pippard MJ, et al. (1986) Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 2: 1175–8

    Article  PubMed  CAS  Google Scholar 

  74. Wu HF, Lundblad RL, Church FC (1995) Neutralization of heparin activity by neutrophil lactoferrin. Blood 85: 421–8

    PubMed  CAS  Google Scholar 

  75. Zachee P, Vermylen J, Boogaerts MA (1994) Hematologic aspects of end-stage renal failure. Ann Hematol 69: 33–40.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Anästhesiologie und Intensivmedizin LKH Universitätsklinikum Graz, Auenbruggerplatz 29, A-8036, Graz

    W. TOLLER

Authors
  1. W. TOLLER
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universität Graz Klinik für Anästhesiologie und Intensivmedizin Landeskrankenhaus Graz, Auenbruggerplatz 29, A-8036, Graz, Österreich

    W.F. List

  2. Institut für Anästhesiologie und operative Intensivmedizin Klinikum Stadt Hanau, Leimenstraße 20, 63450, Hanau, Deutschland

    P.M. Osswald

  3. Institut für Anästhesiologie und operative Intensivmedizin Klinikum Stadt Hanau, Leimenstraße 20, 63450, Hanau, Deutschland

    I. Hornke

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

TOLLER, W. (2003). Perioperative dentale Komplikationen. In: List, W., Osswald, P., Hornke, I. (eds) Komplikationen und Gefahren in der Anästhesie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55858-0_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55858-0_23

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-66433-8

  • Online ISBN: 978-3-642-55858-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation